Global Silver Sulfadiazine Market: Snapshot
The global silver sulfadiazine market is prognosticated to receive a robust growth in demand with the dire need for reliable medications to treat or prevent infection of wounds in patients with severe burns. Most of the time and for more effective usage, silver sulfadiazine is employed with other types of treatment. In order to protect an open wound from infection, silver sulfadiazine could work by ceasing the growth of the impeding bacteria. This could help to avoid the spread of infection into the blood, which can lead to more serious complications such as sepsis or blood infection, or to the adjoining skin of the patient.
Belonging to sulfa antibiotics, a premier class of drugs, silver sulfadiazine produces better results with the healing process of burn wounds if a recommended procedure is followed during treatment. Healthcare professionals would usually remove the debris from the wounded skin and clean the area before applying silver sulfadiazine. The usage of sterile technique during application incorporates the engagement of sterile application tools and precautionary equipment such as sterile gloves.
From an infection in a burn wound to minor skin infections and skin ulcer, all of such conditions could be treated with the involvement of silver sulfadiazine. Any serious side effect caused on account of the use of silver sulfadiazine during burn wound treatment could be reported to the MedWatch Adverse Event Reporting program by the Food and Drug Administration (FDA). It is always advised to administer silver sulfadiazine in proper proportions and avoid over dosages to prevent complications.
Silver sulfadiazine is an antibacterial drug used for making personal care products such as anti-burn creams. Silver sulfadiazine is listed in the World Health Organization’s List of Essential Medicines and is widely used as an antibiotic for treating second and third degree burns on the skin. Silver sulfadiazine prevents the growth of bacteria and yeast on the skin. This drug is also commonly used to treat urinary tract infections (UTIs). Sulfadiazine, when combined with pyrimethamine, is used for curing the disease Toxoplasmosis. The typical Silver sulfadiazine anti-burn lotion/creams contain 1 percent silver sulpahdiazine in it. Maintaining this concentration is really important as silver when used in excessive quantities shows toxic effects. The healing capacity of silver sulfadiazine has been subject to wide speculation and numerous research studies. Cochrane, a non-profit organization, does not recommend the use of silver sulfadiazine as wounds take longer to heal when treated with medicines containing silver sulfadiazine. Despite varied market opinions; silver sulfadiazine remains to be one of the most popular medicines for treatment on burns as it’s is considered to be a powerful medication for burn wounds. Additionally, silver sulfadiazine is used in majority of the hospitals in North America as it is considered the most powerful treatment for burns. Silver sulfadiazine has been known to cause side effects such as nausea, dizziness and loss of appetite. Pregnant mothers and infants are recommended against the consumption of silver sulfadiazine in order to avoid these side effects. People having allergy to sulfa drugs are also advised not to use this medicine. These factors have limited the use of the compound in the global market.
Burn injuries have reached its epidemic proportions and are considered a healthcare problem more serious than other epidemics such as polio. According to the National Fire Protection Association (NFPA), a civilian death from fire occurs about every two hours in the U.S., which in turn have increased the demand for the wound-care products. Silver-containing wound dressings such as silver sulfadiazine has proved their effectiveness and is the most widely used medicine to cure burn injuries. Owing to this, North America has emerged as the largest consumer as well as producer for anti-burn products. The U.S. Government grants funds for the research and development of medicines to fight burn wounds, which has subsequently increased the production of Silver sulfadiazine and other similar products. The market in Asia Pacific is still relatively unexplored.
However, countries such as China, India, Australia and Japan are expected to emerge as new players in the wound care market and are anticipated to serve as new revenue generators over the forecast period. Silver sulfadiazine is losing its edge as the major product of this industry as it has lot of undesired side effects due to which the effectiveness of Silver sulfadiazine is still being debated upon. Furthermore, the rising price of Silver, which is one of the prime raw materials for the production of silver sulfadiazine, is a matter of concern. In addition, for improving synthetic dressing materials, advanced technologies in wound treatment which include the xenogeneic tissue scaffold, endovascular arterial repair techniques, endoscopic subfascial ligation of venous perforators, recombinant growth factors, bilayered human dermal substitutes, and hyperbaric oxygen therapy is forcing silver sulfadiazine to lose its market importance.
Johnson & Johnson Limited, 3M Company, Baxter International Inc Monarch Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. are some of the key players in this market.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments